Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells
Authors
Keywords
Cellular prion protein, Hsp70/90 organizing protein, Glioblastoma, Stem cells, Proliferation
Journal
Stem Cell Research & Therapy
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-17
DOI
10.1186/s13287-017-0518-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells
- (2016) Tonielli Cristina Sousa de Lacerda et al. CLINICAL & EXPERIMENTAL METASTASIS
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- The prion protein inhibits monocytic cell migration by stimulating 1 integrin adhesion and uropod formation
- (2015) D. D. Richardson et al. JOURNAL OF CELL SCIENCE
- Targeting prion protein interactions in cancer
- (2015) Tiago G Santos et al. Prion
- Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
- (2015) Hayley P. Ellis et al. Frontiers in Oncology
- Disruption of prion protein–HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival
- (2014) M H Lopes et al. ONCOGENE
- Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes
- (2013) Daniel Stieber et al. ACTA NEUROPATHOLOGICA
- CD44-Positive Cancer Stem Cells Expressing Cellular Prion Protein Contribute to Metastatic Capacity in Colorectal Cancer
- (2013) L. Du et al. CANCER RESEARCH
- Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90
- (2013) Mirela Matokanovic et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Prognostic value of Musashi-1 in gliomas
- (2013) Rikke H. Dahlrot et al. JOURNAL OF NEURO-ONCOLOGY
- CD44/Cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients
- (2013) Yuanyuan Cheng et al. MOLECULAR CARCINOGENESIS
- Tumor Stress-Induced Phosphoprotein1 (STIP1) as a Prognostic Biomarker in Ovarian Cancer
- (2013) Angel Chao et al. PLoS One
- Conserved Roles of the Prion Protein Domains on Subcellular Localization and Cell-Cell Adhesion
- (2013) Gonzalo P. Solis et al. PLoS One
- Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting
- (2012) Luca Persano et al. BIOCHEMICAL PHARMACOLOGY
- The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells
- (2012) Tullio Florio et al. DRUG DISCOVERY TODAY
- Requirement of Cellular Prion Protein for Intestinal Barrier Function and Mislocalization in Patients With Inflammatory Bowel Disease
- (2012) Constance S.V. Petit et al. GASTROENTEROLOGY
- Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells
- (2012) Tomohisa Horibe et al. Molecular Cancer
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells
- (2011) Giulia Barbieri et al. Autophagy
- RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation
- (2011) Naomi Walsh et al. CANCER LETTERS
- Neuritogenesis: the prion protein controls β1 integrin signaling activity
- (2011) Damien Loubet et al. FASEB JOURNAL
- TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells
- (2011) Dongxiao Zhuang et al. INTERNATIONAL JOURNAL OF CANCER
- Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent
- (2011) Tomohisa Horibe et al. Journal of Translational Medicine
- Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
- (2011) Justin D. Lathia et al. PLoS One
- The Importance of the Stem Cell Marker Prominin-1/CD133 in the Uptake of Transferrin and in Iron Metabolism in Human Colon Cancer Caco-2 Cells
- (2011) Erika Bourseau-Guilmain et al. PLoS One
- Enhanced Neural Progenitor/Stem Cells Self-Renewal via the Interaction of Stress-Inducible Protein 1 with the Prion Protein
- (2011) Tiago G. Santos et al. STEM CELLS
- Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma
- (2010) Hiroshi Kubota et al. CELL STRESS & CHAPERONES
- The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosisviaNotch-1 and p21WAF1/CIP1
- (2010) Martin Götte et al. INTERNATIONAL JOURNAL OF CANCER
- Pro-prion Binds Filamin A, Facilitating Its Interaction with Integrin β1, and Contributes to Melanomagenesis
- (2010) Chaoyang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of Embryonic Cell Adhesion by the Prion Protein
- (2009) Edward Málaga-Trillo et al. PLOS BIOLOGY
- The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel
- (2008) Q.-Q. Li et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Knockdown of the co-chaperone Hop promotes extranuclear accumulation of Stat3 in mouse embryonic stem cells
- (2008) Victoria M. Longshaw et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Physiology of the Prion Protein
- (2008) Rafael Linden et al. PHYSIOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now